Product Information
GABAPENTIN 100 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0210 per EA under NDC 69097081307. Its NADAC has been published 516 times since Aug 10, 2016.
Strength
100 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081307
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA090705On Market Since
6/29/2016
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 100 MG CAPSULE has been published 516 times since Aug 10, 2016, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0210 per EA |
|---|---|
| All-time high | $0.0374 (Nov 14, 2018) |
| All-time low | $0.0186 (Nov 20, 2024) |
| 52-week high | $0.0223 |
| 52-week low | $0.0210 |
| Median price | $0.0280 |
| Average price | $0.0280 |
| Largest weekly change | +24.9% (Jul 18, 2018) |
| Weeks tracked | 516 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0210 per EA (NDC 69097081307), effective Jun 24, 2026.
How has the price of GABAPENTIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 28.8%. It has been tracked across 516 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?
Since Aug 10, 2016, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0186 (Nov 20, 2024) to a high of $0.0374 (Nov 14, 2018), with a median of $0.0280 per EA.
Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 100 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 100 MG CAPSULE?
GABAPENTIN 100 MG CAPSULE (NDC 69097081307) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification